Wells Fargo’s CRISPR Therapeutics CRSP Stock Holding History
| Quarter | Market Value | Status | Shares |
Shares Change % | Trade Value | Portfolio Weight | Portfolio Position | |
|---|---|---|---|---|---|---|---|---|
|
2025
Q2 | $11.5M | Sell |
235,740
-29,786
| -11% | -$1.45M | ﹤0.01% | 1635 |
|
|
2025
Q1 | $9.04M | Buy |
265,526
+45,403
| +21% | +$1.55M | ﹤0.01% | 1737 |
|
|
2024
Q4 | $8.66M | Buy |
220,123
+17,094
| +8% | +$673K | ﹤0.01% | 1754 |
|
|
2024
Q3 | $9.54M | Sell |
203,029
-24,570
| -11% | -$1.15M | ﹤0.01% | 1698 |
|
|
2024
Q2 | $12.3M | Buy |
227,599
+11,205
| +5% | +$605K | ﹤0.01% | 1454 |
|
|
2024
Q1 | $14.7M | Buy |
216,394
+47,997
| +29% | +$3.27M | ﹤0.01% | 1314 |
|
|
2023
Q4 | $10.5M | Sell |
168,397
-34,841
| -17% | -$2.18M | ﹤0.01% | 1515 |
|
|
2023
Q3 | $9.22M | Buy |
203,238
+2,796
| +1% | +$127K | ﹤0.01% | 1516 |
|
|
2023
Q2 | $11.3M | Sell |
200,442
-6,153
| -3% | -$345K | ﹤0.01% | 1456 |
|
|
2023
Q1 | $9.34M | Buy |
206,595
+69,932
| +51% | +$3.16M | ﹤0.01% | 1567 |
|
|
2022
Q4 | $5.56M | Sell |
136,663
-2,989
| -2% | -$122K | ﹤0.01% | 1899 |
|
|
2022
Q3 | $9.13M | Buy |
139,652
+1,145
| +0.8% | +$74.8K | ﹤0.01% | 1515 |
|
|
2022
Q2 | $8.42M | Sell |
138,507
-57,380
| -29% | -$3.49M | ﹤0.01% | 1608 |
|
|
2022
Q1 | $12.3M | Buy |
195,887
+3,698
| +2% | +$232K | ﹤0.01% | 1599 |
|
|
2021
Q4 | $14.6M | Sell |
192,189
-270,651
| -58% | -$20.5M | ﹤0.01% | 1508 |
|
|
2021
Q3 | $51.8M | Sell |
462,840
-3,692
| -0.8% | -$413K | 0.01% | 1007 |
|
|
2021
Q2 | $75.5M | Buy |
466,532
+86,690
| +23% | +$14M | 0.02% | 806 |
|
|
2021
Q1 | $46.3M | Sell |
379,842
-84,676
| -18% | -$10.3M | 0.01% | 1062 |
|
|
2020
Q4 | $71.1M | Sell |
464,518
-96,142
| -17% | -$14.7M | 0.02% | 795 |
|
|
2020
Q3 | $46.9M | Buy |
560,660
+18,258
| +3% | +$1.53M | 0.01% | 901 |
|
|
2020
Q2 | $39.9M | Buy |
542,402
+40,883
| +8% | +$3M | 0.01% | 956 |
|
|
2020
Q1 | $21.3M | Buy |
501,519
+94,137
| +23% | +$3.99M | 0.01% | 1188 |
|
|
2019
Q4 | $24.8M | Sell |
407,382
-113,523
| -22% | -$6.91M | 0.01% | 1326 |
|
|
2019
Q3 | $21.4M | Sell |
520,905
-83,000
| -14% | -$3.4M | 0.01% | 1391 |
|
|
2019
Q2 | $28.4M | Buy |
603,905
+116,540
| +24% | +$5.49M | 0.01% | 1243 |
|
|
2019
Q1 | $17.4M | Buy |
487,365
+12,786
| +3% | +$457K | 0.01% | 1535 |
|
|
2018
Q4 | $13.6M | Buy |
474,579
+45,684
| +11% | +$1.31M | ﹤0.01% | 1637 |
|
|
2018
Q3 | $19M | Buy |
428,895
+65,238
| +18% | +$2.89M | 0.01% | 1532 |
|
|
2018
Q2 | $21.4M | Sell |
363,657
-97,720
| -21% | -$5.74M | 0.01% | 1446 |
|
|
2018
Q1 | $21.1M | Buy |
461,377
+439,860
| +2,044% | +$20.1M | 0.01% | 1414 |
|
|
2017
Q4 | $505K | Buy |
21,517
+3,165
| +17% | +$74.3K | ﹤0.01% | 4287 |
|
|
2017
Q3 | $328K | Buy |
18,352
+10,365
| +130% | +$185K | ﹤0.01% | 4479 |
|
|
2017
Q2 | $128K | Buy |
7,987
+6,560
| +460% | +$105K | ﹤0.01% | 4857 |
|
|
2017
Q1 | $31K | Buy |
1,427
+447
| +46% | +$9.71K | ﹤0.01% | 5267 |
|
|
2016
Q4 | $20K | Buy |
+980
| New | +$20K | ﹤0.01% | 5306 |
|